Bill
Bill > HB125
TX HB125
TX HB125Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.
summary
Introduced
07/18/2025
07/18/2025
In Committee
Crossed Over
Passed
Dead
08/15/2025
08/15/2025
Introduced Session
89th Legislature 1st Special Session
Bill Summary
AN ACT relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.
AI Summary
This bill amends the Texas Controlled Substances Act by expanding Schedule IV to include three specific substances: carisoprodol (a muscle relaxant), mifepristone (a medication used in medical abortion), and misoprostol (a drug used to prevent stomach ulcers and also used in medical abortion procedures). The bill modifies Section 481.037 of the Health and Safety Code to add these substances to the list of Schedule IV controlled substances, which means they will be subject to specific regulatory controls and prescription requirements. The changes will apply only to offenses committed on or after January 1, 2026, and for any offenses committed before that date, the previous law will continue to govern. By adding these substances to Schedule IV, the bill aims to increase regulatory oversight and control of these specific medications, potentially addressing concerns about their potential for misuse or inappropriate prescription.
Sponsors (1)
Last Action
Filed (on 07/18/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://capitol.texas.gov/BillLookup/History.aspx?LegSess=891&Bill=HB125 |
BillText | https://capitol.texas.gov/tlodocs/891/billtext/html/HB00125I.htm |
Loading...